The ASR hip implant recall is a complicated recall with details that emerged over time. The key to understanding the DePuy Orthopaedics recall is learning about its history.
DePuy Orthopaedics, Inc., the orthopedic branch of Johnson & Johnson, manufactured two hip implant products that have been part of a recall in 2010. These were the ASR XL Acetabular System, a hip socket and the ASR Hip Resurfacing System, designed for “partial” replacements. (Only the ASR XL Acetabular System was used in patients in the United States. The ASR XL Acetabular or “traditional” system was sold globally.)
In March 2010, DePuy issued an “advisory,” indicating some of its devises were exhibiting early failure. It wasn’t until a New York Times exposé exposing various reports of early failures with the DePuy device that the implants were finally recalled.
DePuy acknowledged the hip implant was experiencing decreased sales after its August recall, and later admitted to the higher than average failure rate.
After the recall, it was exposed that the U.S. Food and Drug Administration knew about the early failure rates of the DePuy ASR XL hip implants since 2008, two years before the recall. They have received nearly 400 complaints of early failure rates, requiring patients to undergo difficult and dangerous revision surgery.
As a Seattle hip replacement recall attorney, I sort through the complicated DePuy case to get you the claim you deserve.
No related posts.
DePuy acknowledged the hip implant was experiencing decreased sales after its August recall, and later admitted to the higher than average failure rate.